Geron | GERN - Ebitda





Ebitda Veränderung Datum
Amgen USD 3.86B 1.28B 2026-03
Bio Techne USD 115.94M 763K 2026-06
Cassava Sciences USD -11.73M 33.44M 2025-09
Cytokinetics USD -169.32M 19.48M 2026-03
Exelixis USD 255.4M 2.89M 2026-06
Genmab DKK 401M 186M 2026-06
Geron USD 3.83M 25.12M 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
Incyte USD 778.57M 410.6M 2026-06
MacroGenics USD -30.2M 52.15M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Novavax USD 19.36M 190.79M 2025-12